首页/数据集/IC<sub>50</sub> of MO and DOX and their combinations on breast cancer cell line.

IC<sub>50</sub> of MO and DOX and their combinations on breast cancer cell line.

NIAID Data Ecosystem2026-03-09 收录

数据链接：

https://figshare.com/articles/dataset/IC_sub_50_sub_of_MO_and_DOX_and_their_combinations_on_breast_cancer_cell_line_/4255922 数据链接链接失效反馈

官方服务：

资源简介：

IC50 of MO and DOX and their combinations on breast cancer cell line.

应用场景：

创建时间：

2016-11-24

癌症生物标志物

肿瘤药物敏感性

Background: REV1 is a member of the translesion synthesis DNA polymerase Y family. It is an essential player in a variety of DNA replication activities, and perform major roles in the production of bo

NIAID Data Ecosystem120

Supplementary Table S1 from Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

化疗难治性AML个体化治疗

肿瘤药物敏感性

- XLSX file 452K, DSRT Oncology drug collection

NIAID Data Ecosystem40

A melanoma mutation panel for individualized treatment of patient-derived melanoma cell cultures. A melanoma mutation panel for individualized treatment of patient-derived melanoma cell cultures

黑色素瘤精准医疗

肿瘤药物敏感性

Purpose: To identify new targets in melanoma for targeted treatment based on a mutational analysis of melanoma cell lines and subsequent individualized treatment combinations. Experimental Design: A s

NIAID Data Ecosystem10

Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed Comparison

胶质母细胞瘤模型

肿瘤药物敏感性

Background Development of clinically relevant tumor model systems for glioblastoma multiforme (GBM) is important for advancement of basic and translational biology. High molecular heterogeneity of GBM

NIAID Data Ecosystem80

Treatment course and toxicities during CHOP chemotherapy in Lilongwe, Malawi.

癌细胞毒性

CHOP化疗方案

Treatment course and toxicities during CHOP chemotherapy in Lilongwe, Malawi.

Figshare2016-03-08 更新10